Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion type Assertion NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_head.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion description "[We studied the incidences, associations, and prognostic roles of NOTCH1 and SF3B1 mutations (NOTCH1(mut), SF3B1(mut)) as compared with TP53(mut) in fludarabine-refractory chronic lymphocytic leukemia (CLL) patients treated with alemtuzumab in the CLL2H trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_provenance.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion evidence source_evidence_literature NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_provenance.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion SIO_000772 23821658 NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_provenance.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion wasDerivedFrom befree-20140225 NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_provenance.
- NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_assertion wasGeneratedBy ECO_0000203 NP705174.RAVFVyE0MGLImyS2vATzhbE00jWm0teIQO37n3yUgLh3c130_provenance.